Spatially-Variant Normal Tissue Constraint Optimization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current radiation treatment plans often create hotspots in healthy tissues due to the inability to accurately discriminate between target and adjacent tissues, leading to inadequate dose distribution and exposure constraints.

Innovation Solution

A control circuit determines a spatially-variant normal tissue constraint based on dose distribution, allowing for flexible and nuanced optimization of radiation treatment plans by penalizing excessive dose levels at specific distances from the target volume, using a free-form function to minimize collateral exposure to healthy tissues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If a constraint is imposed on specifically-identified healthy tissues to minimize hotspots, then the radiation dose to healthy tissue is reduced, but the treatment plan becomes more complex and may not adequately account for spatial variations in dose distribution

Engineering Contradiction:
Improveradiation dose to healthy tissueVSAvoidtreatment plan complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent applies local quality by imposing different constraint values on different portions of healthy tissue based on their spatial relationship to the target volume. Specifically, healthy tissue closer to the target volume is imposed with a higher constraint value while healthy tissue further away is imposed with a lower constraint value, creating a spatially-variant constraint structure that accounts for local dose distribution characteristics

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent implements dynamics by using an exponential fall-off curve to dynamically adjust constraint values based on distance from the target volume. The constraint value varies continuously as a function of distance, allowing the treatment plan to adapt to spatial variations in dose distribution rather than applying static uniform constraints

Inventive Principle:
Principle #15Dynamics

2Ease of operation

If a same constraint value is applied to all portions of healthy tissue, then the treatment plan is simpler to implement, but hotspots are created in healthy tissue closer to the target volume

Engineering Contradiction:
Improvetreatment plan implementationVSAvoidhotspots in healthy tissue
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent resolves this contradiction by applying different constraint values to different portions of healthy tissue based on their local characteristics. The constraint value is not uniform but varies spatially, with higher values assigned to healthy tissue closer to the target volume where hotspots are more likely to occur, and lower values assigned to healthy tissue further away

Inventive Principle:
Principle #3Local quality

3Measurement precision

If an exponential fall-off curve is used to vary constraints spatially, then dose distribution accuracy is improved, but the treatment plan optimization becomes more computationally intensive

Engineering Contradiction:
Improvedose distribution accuracyVSAvoidoptimization computation time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent applies parameter changes by using an exponential fall-off curve to vary the constraint parameter spatially based on distance from the target volume. This mathematical relationship provides a systematic way to adjust constraint values to achieve more accurate dose distribution while maintaining a manageable optimization process through the use of a well-defined functional form

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS9387345B2Apparatus and method pertaining to determining a spatially-variant normal tissue constraint as a function of dose distribution
Publication Date: 2016.07.12 SIEMENS HEALTHINEERS INTERNATIONAL AG
  • US9387345B2 patent drawing
  • US9387345B2 patent drawing

AI summary

A control circuit optimizes a radiation-treatment plan (as regards treating at least one target volume for a given patient) by automatically determining a spatially-variant normal tissue constraint as a function, at least in part, of dose distribution for normal tissue that is proximal to the target volume. If desired, the control circuit can repeatedly determine spatially-variant normal tissue constraints while optimizing the radiation-treatment plan. This automatic determination can comprise evaluating dose distributions at specific different distances from the target volume. So configured, the control circuit can effect such evaluation by penalizing, during the optimization of the radiation-treatment plan, dose distribution levels that exceed a predetermined distribution property (such as an aggregation value for the dose values including, but not limited to, an average value of dose values for each of the given specific different distances) at a given one of the specific different distances.